Stephane Bancel CEO of Moderna
In Good Company with Nicolai Tangen
00:00
Vaccine Development in a Crisis
This chapter covers Moderna's urgent response to the COVID-19 pandemic and the ethical considerations of developing a vaccine in a global health crisis. It highlights the innovative use of mRNA technology and the commitment to public welfare, alongside the challenges faced by the scientific community during this unprecedented time.
Transcript
Play full episode
